Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roh

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
JNCI Cancer Spectrum|December 17, 2025
Disparities in cardiometabolic and cardiovascular risk after breast cancer: the pathways heart studyAndrea E Diaz, Marilyn L Kwan, Cecile A Laurent, et al.
Cell Death and Differentiation|August 20, 2013
Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degenerationY Murakami, H Matsumoto, M Roh, et al.
JACC. Advances|September 6, 2024
Blood Pressure and Cardiovascular Risk in Women With Breast Cancer: The Pathways Heart StudyDouglas J Leedy, Jay M Voit, Eileen Rillamas-Sun, et al.
Cancer|April 25, 2023
Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways StudyShannon M Conroy, Julie Von Behren, Marilyn L Kwan, et al.
Breast Cancer Research and Treatment|November 4, 2023
Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery systemElizabeth D Kantor, Kelli O'Connell, Isaac J Ergas, et al.
Journal of Dental Research|June 10, 2026
Restoring Cellular Homeostasis as a Therapeutic Strategy for PeriodontitisH Jang, J Im, D-S Lee, et al.
JAMA Network Open|March 22, 2024
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast CancerThaer Khoury, Lucas Mendicino, Rochelle Payne Ondracek, et al.
Breast Cancer Research and Treatment|July 8, 2024
A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancerEmily Liang, Michael Beshara, Haiyang Sheng, et al.
American Journal of Epidemiology|December 6, 2023
Environmental and occupational exposures and prognosis in patients with non-muscle-invasive bladder cancer in the Be-Well StudyZinian Wang, Marilyn L Kwan, Reina Haque, et al.
JAMA Oncology|June 1, 2016
Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) StudyHeather Greenlee, Alfred I Neugut, Laura Falci, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
JNCI Cancer Spectrum|December 17, 2025
Disparities in cardiometabolic and cardiovascular risk after breast cancer: the pathways heart studyAndrea E Diaz, Marilyn L Kwan, Cecile A Laurent, et al.
Cell Death and Differentiation|August 20, 2013
Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degenerationY Murakami, H Matsumoto, M Roh, et al.
JACC. Advances|September 6, 2024
Blood Pressure and Cardiovascular Risk in Women With Breast Cancer: The Pathways Heart StudyDouglas J Leedy, Jay M Voit, Eileen Rillamas-Sun, et al.
Cancer|April 25, 2023
Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways StudyShannon M Conroy, Julie Von Behren, Marilyn L Kwan, et al.
Breast Cancer Research and Treatment|November 4, 2023
Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery systemElizabeth D Kantor, Kelli O'Connell, Isaac J Ergas, et al.
Journal of Dental Research|June 10, 2026
Restoring Cellular Homeostasis as a Therapeutic Strategy for PeriodontitisH Jang, J Im, D-S Lee, et al.
JAMA Network Open|March 22, 2024
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast CancerThaer Khoury, Lucas Mendicino, Rochelle Payne Ondracek, et al.
Breast Cancer Research and Treatment|July 8, 2024
A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancerEmily Liang, Michael Beshara, Haiyang Sheng, et al.
American Journal of Epidemiology|December 6, 2023
Environmental and occupational exposures and prognosis in patients with non-muscle-invasive bladder cancer in the Be-Well StudyZinian Wang, Marilyn L Kwan, Reina Haque, et al.
JAMA Oncology|June 1, 2016
Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) StudyHeather Greenlee, Alfred I Neugut, Laura Falci, et al.
Pageof 13